{"id":"W2884380775","doi":"10.2337/dc18-0623","title":"Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial","year":2018,"lang":"en","type":"article","venue":"Diabetes Care","topic":"Diabetes Management and Research","field":"Medicine","cited_by":252,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"AstraZeneca; Bristol-Myers Squibb","keywords":"Dapagliflozin; Medicine; Hypoglycemia; Placebo; Diabetes mellitus; Glycemic; Internal medicine; Diabetic ketoacidosis; Adverse effect; Insulin; Type 2 diabetes; Randomized controlled trial; Type 1 diabetes; Urology; Gastroenterology; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002015231,0.0003649233,0.003104144,0.0003238557,0.0001337858,0.0000667584,0.0002686622,0.0001226458,0.00005840979],"category_scores_gemma":[0.004380939,0.0001901565,0.0002357634,0.0005464067,0.00059304,0.00009646247,0.0001716357,0.0003133978,0.00002783549],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005550036,"about_ca_system_score_gemma":0.0001002683,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003521271,"about_ca_topic_score_gemma":0.00006575947,"domain_scores_codex":[0.9957744,0.001065729,0.001198421,0.0005427909,0.0008333091,0.0005853425],"domain_scores_gemma":[0.9939834,0.004116915,0.0004392515,0.0006258602,0.0006848284,0.0001497639],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7829558,0.001104991,0.208736,0.00004570947,0.00168841,0.000002869578,0.001776977,0.000003257661,0.00002730617,0.000007389867,0.0001307835,0.003520477],"study_design_scores_gemma":[0.847206,0.007290733,0.1425183,0.0002521946,0.001172817,4.626496e-9,0.0006973149,0.0004475239,0.00009694345,0.00002406504,0.0001101314,0.0001839453],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9764479,0.0006781335,6.779985e-7,0.0002570587,0.0003571964,0.02072863,0.00005487435,0.00003944494,0.001436098],"genre_scores_gemma":[0.9984905,0.00002107266,0.00004825784,0.0001365097,0.0002303451,0.000582164,0.0002355072,0.0000416342,0.0002139884],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0662177,"threshold_uncertainty_score":0.7754356,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01388334851724713,"score_gpt":0.258403644830267,"score_spread":0.2445202963130198,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}